Webinar
How Regulatory Information Management Systems can support Life Sciences
20 January 2021 | Online
Catch the latest updates on regulatory responsiveness since Covid-19 has triggered an unprecedented disruption to global life sciences and public health sectors.
Covid-19 has triggered unprecedented disruption to global life sciences and public health, exposing some gaping holes in drug companies’ product insights and regulatory responsiveness. In this webinar, David Gwyn will explore some of the lessons learnt in 2020 to assess how companies might transform their regulatory operations in 2021, to improve their adaptability and become better equipped for continued uncertainty.
He will demonstrate how pharmaceutical companies must get their global operations in order and render their regulatory information more tightly interwoven. Whatever organizations’ immediate agenda, an effective plan for 2021 in relation to RIM transformation must be put in place.
Why attend?
In this webinar, you'll learn about:
- Long-term remote working/team fragmentation
- The relative ease of managing regulatory processes across distance when all contributing systems are tightly welded together in a unified manner
- The scope for leveraging a unified RIM solution to accelerate the drug development process and scope for maintaining production during periods of disruption.
Meet the Speakers
REGISTRATION
How Regulatory Information Management Systems can support Life Sciences
20 January | 2:00 - 3:00 PM GMT